⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBIX News
Neurocrine Biosciences Inc
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
prnewswire.com
NBIX
Global Telehealth Market is Projected to Cross the USD 2 Trillion Mark by 2034, Driven by Digital Healthcare Transformation | DelveInsight
prnewswire.com
TDOC
CSCO
PHG
IBM
MDT
AMWL
GEHC
HPQ
DOX
ISRG
BMBL
ADMA
FLEX
INTC
GOOG
MSFT
AMZN
NVDA
AAPL
TSLA
JNJ
PFE
ABBV
BMY
MRK
XRAY
SYK
BDX
LULU
ROST
ULTA
COST
MCHP
ON
ADI
TXN
QCOM
AMD
SIRI
CMCSA
VZ
T
MU
AMAT
KLAC
LRCX
WDC
SE
BABA
JD
NTES
PDD
IQ
BIDU
FOX
FOXA
NFLX
DIS
CMG
MCD
SBUX
YUM
CVS
EL
ORCL
CRM
NOW
ADBE
INTU
PAYX
ADP
MA
V
AXP
GS
JPM
BAC
WFC
MS
CME
ICE
SCHW
AMGN
GILD
REGN
BIIB
AZN
NVS
SNY
TEVA
CPRT
ALGN
EXPE
BKNG
MAR
HLT
IHG
WYNN
LVS
MGM
EXAS
ACAD
ALKS
VRTX
CRSP
EDIT
NTLA
NBIX
ALNY
BMRN
IDXX
ZBRA
HON
ETR
NEE
DUK
SO
XOM
CVX
SHEL
GOOGL
META
TMUS
AVGO
MRVL
NXPI
INFY
DELL
HPE
LEN
BRK.B
BRK.A
UNH
CI
CNC
ELV
HCA
EBS
TTWO
EA
NTDOY
SONY
GE
BA
GD
LMT
RTX
NOC
CAT
DE
AGCO
CNH
IRTC
HOLX
TNDM
PODD
RMD
MASI
SNOW
DDOG
PANW
FTNT
CRWD
OKTA
SNPS
CDNS
BetterInvesting™ Magazine Update on Equifax Inc. (NYSE: EFX) and Neurocrine Bio In. (NASDAQ: NBIX)
prnewswire.com
EFX
NBIX
Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026
prnewswire.com
NBIX
Syndromic Multiplex Panels Market Strategies, Trends and Forecast 2025-2029: Cost Efficiency, Diagnostic Accuracy, Single-Visit Testing, and Pandemic-Driven Uptake Support Growth
globenewswire.com
ABT
BDX
BIIB
CHE
CTAS
CUE
DHR
DIA
EXPE
GEHC
GILD
HOLX
ICUI
ILMN
INCY
ISRG
LH
LULU
MRNA
NBIX
NOC
ORCL
PDD
PFE
QGEN
QDEL
REGN
ROKU
SNPS
TMO
TSLA
VRTX
XRAY
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia
prnewswire.com
NBIX
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
ABBV
NBIX
JNJ
NVS
AMGN
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
ABBV
NBIX
JNJ
NVS
AMGN
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
prnewswire.com
NBIX
Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies
prnewswire.com
NBIX